6 Sept 2026Open access
Analysis of polypeptide derivati1ves targeting the melanocortin-4 receptor for treating hypoactive sexual desire disorderPublisher siteEclética Química, Regulation of Appetite and Obesity
UniversitiesAbel Kolawole Oyebamiji
Active, last published 2026
In computational drug discovery methods
Abel Kolawole
Oyebamiji
Scholar“Research focused on Computational Drug Discovery Methods and adjacent fields.”
Nigerian Geological Survey Agency
Claim Your Profile21
H-index
2.0k
Citations
Abel has not officially claimed their profile. If you are Abel, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
bel Kolawole Oyebamiji is a researcher working on Computational Drug Discovery Methods. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Abel's work has been cited 1,961 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Computational Drug Discovery Methods×37Synthesis and biological activity×34Nanoparticles: synthesis and applications×15Synthesis and Characterization of Heterocyclic Compounds×12Click Chemistry and Applications×11
04 · Where I am
Affiliations
Affiliation on published researchNigerian Geological Survey AgencyDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
53 works17 Aug 2026
Activity cliffs resist prediction within and across protein kinases: a leakage-controlled machine-learning analysis of structure-potency discontinuitiesPublisher siteBioorganic Chemistry, Computational Drug Discovery Methods
1 Aug 2026Open access
PlasmidRiskNet: An explainable machine-learning framework for antimicrobial resistance plasmid risk stratificationPublisher siteNew Microbes and New Infections, Antibiotic Resistance in Bacteria
12 Jun 2026
Leveraging on Computational Strategies to Alleviate Vaso-Occlusive Crises in Sickle Cell DiseasePublisher siteJournal of Pharmaceutical Innovation, Hemoglobinopathies and Related Disorders
11 May 2026Open access
Phytosynthesis of gold nanoparticles and their potential applications as anticancer agent: a reviewPublisher siteDiscover Applied Sciences, Nanoparticles: synthesis and applications
23 Mar 2026Open access
Deciphering the mechanisms underlying the dual-target inhibition of carbohydrate-digesting and neurodegenerative enzymes by Syzygium aromaticum (L.) Merr. & L.M. via molecular docking and dynamics simulationsPublisher siteScientific Reports, Natural Antidiabetic Agents Studies
1 Jan 2026Open access2cites
Computational studies on Morpho Butterfly Wings-based compounds as potential Human 3-alpha Hydroxysteroid Dehydrogenase type 3 inhibitorsPublisher siteIn Silico Research in Biomedicine, Synthesis and Characterization of Pyrroles
30 Dec 2025Open access
Retraction notice to "Green synthesis of copper oxide nanoparticles for biomedical application and environmental remediation" [Heliyon 6 (2020) e04508]Publisher siteHeliyon, Copper-based nanomaterials and applications
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Abel?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you